Is the decreasing responsiveness of axial motor symptoms to L-dopa in elderly parkinsonian patients related to age-associated nonparkinsonian pathologies?
Ransmayr, G.; Künig, G.; Neubauer, M.; Wagner, M.; Bösch, S.; Kreczy-Kleedorfer, B.
Advances in Neurology 60: 685-689
1993
ISSN/ISBN: 0091-3952 PMID: 8420211 Document Number: 420516
Document emailed within 1 workday
Related Documents
Peppe, A.; Dambrosia, J.M.; Chase, T.N. 1993: Risk factors for motor response complications in L-dopa-treated parkinsonian patients Advances in Neurology 60: 698-702Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Gersten, J.W.; Marshall, C.; Dillon, T.; Schneck, S.A.; Orr, W.; Nelson, C. 1972: External work of walking and functional capacity in Parkinsonian patients treated with L-dopa Archives of Physical Medicine and Rehabilitation 53(12): 547-553
Liu, C.; Mao, C. 2014: Exploring new assessment methods to evaluate motor and non-motor symptoms comprehensively and objectively in patients with Parkinson's disease Zhonghua Yi Xue Za Zhi 94(11): 801-803
Salzman, C.; Jeste, D.V.; Meyer, R.E.; Cohen-Mansfield, J.; Cummings, J.; Grossberg, G.T.; Jarvik, L.; Kraemer, H.C.; Lebowitz, B.D.; Maslow, K.; Pollock, B.G.; Raskind, M.; Schultz, S.K.; Wang, P.; Zito, J.M.; Zubenko, G.S. 2008: Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy Journal of Clinical Psychiatry 69(6): 889-898
Ciuca, I.; Bulandra, R.; Serbanesco, L.; Ninosu, N. 1972: Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes Revue Neurologique (Paris) 127(2): 305-308
Fischer, P.A. 1974: Therapy of Parkinsonian syndrome using L-dopa. Current state and problems Der Nervenarzt 45(12): 617-627
Ambrosetto, C.; Martinelli, P. 1971: Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa Minerva Medica 62(82): 4017-4019
McMeekin, H. 2007: Treatment of bipolar disorder, restless legs syndrome and parkinsonian symptoms using lamotrigine: a report of seven patients Journal of the South Carolina Medical Association 103(3): 69-73
Dong, H.; Liu, C.; Hu, X. 2014: Effects of non-motor symptoms on health-related quality of life in Parkinson's disease Zhonghua Yi Xue Za Zhi 94(11): 813-815
Del Dotto, P.; Colzi, A.; Pardini, C.; Lucetti, C.; Dubini, A.; Grimaldi, R.; Bonuccelli, U. 1995: Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients Journal of Neural Transmission. Supplementum 45: 259-265
Quattrini, A.; Paggi, A.; Forastieri, L.; Del Pesce, M.; Di Bella, P. 1979: Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) Rivista di Patologia Nervosa e Mentale 99(5): 289-297
Rabadeau Dumas, J.L.; Rondot, P.; Cardon, P. 1977: Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor Therapie 32(2): 161-172
Shan, D.E.; Yeh, S.I. 1996: An add-on study of selegiline to Madopar in the treatment of parkinsonian patients with dose-related fluctuations: comparison between Jumexal and Parkryl Zhonghua Yi Xue Za Zhi 58(4): 264-268
Chase, T.N.; Oh, J.D. 2000: Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications Annals of Neurology 47(4 Suppl 1): S122
Narabayashi, H. 1982: Generating mechanism and treatment of parkinsonian symptoms Rinsho Shinkeigaku 22(12): 1055-1062
Cabo-López, I.; García-Bermejo, P.; García-Ruiz, P.J. 2007: Levodopa withdrawal symptoms in a non-Parkinsonian patient Revista de Neurologia 45(3): 190
Stella, F.; Bucken-Gobbi, L.T.; Gobbi, S.; Sant'Ana-Simões, C. 2007: Depressive symptoms and motor condition in Parkinson's disease patients Revista de Neurologia 45(10): 594-598
Myslobodsky, M.S.; Holden, T.; Sandler, R. 1986: Parkinsonian symptoms in tardive dyskinesia. A prevalence study South African Medical Journal 69(7): 424-426